Matěj Škorvánek
Matěj Škorvánek publishes mostly in Neurology, Cellular and Molecular Neuroscience and Genetics, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Genetic Neurodegenerative Diseases.
- World rank
- #533,954 of 7,710,434 ranked researchers
- Rank in Slovakia
- #150 of 12,450
- Works
- 162
- Citations
- 3k
- Citations per work
- 18.8
What does Matěj Škorvánek research?
Matěj Škorvánek's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6137.7%
- Medicine6137.7%
- Everything else5131.5%
- Life Sciences5030.8%
- Biochemistry, Genetics and Molecular Biology2515.7%
- Neuroscience2415.1%
- 1Neurology33% of their works
- 2Cellular and Molecular Neuroscience10% of their works
- 3Genetics8% of their works
- 4Molecular Biology8% of their works
- 5Neurology5% of their works
- 6Physiology4% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Genetic Neurodegenerative Diseases
- Genomics and Rare Diseases
- Botulinum Toxin and Related Neurological Disorders
- Neurological diseases and metabolism
- Restless Legs Syndrome Research
- Genetics and Neurodevelopmental Disorders
Which keywords describe Matěj Škorvánek's research?
The keywords of their largest research topics: Parkinson's Disease, Mitochondrial Dysfunction, Neurodegeneration, Diagnostic Criteria, Neurological Disorders, a-Synuclein, Dopaminergic Neurons and Deep Brain Stimulation.
- Rett Syndrome
- Restless Legs Syndrome
- Pantothenate Kinase
- Neurotoxins
- Sequence Interpretation
- Genetic Mutations
- Huntington's Disease
- Deep Brain Stimulation
- Dopaminergic Neurons
- Diagnostic Criteria
- Mitochondrial Dysfunction
- Parkinson's Disease
- Neurodegeneration
- Neurological Disorders
- a-Synuclein
- Subthalamic Nucleus
- Protein Aggregation
- Genetic Variants
- Botulinum Toxin
- Brain Iron Accumulation
- Epidemiology
- Fragile X Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Parkinson's Disease1112 topics
- Mitochondrial Dysfunction1103 topics
- Neurodegeneration812 topics
- Diagnostic Criteria782 topics
- Neurological Disorders763 topics
- Dopaminergic Neurons651 topic
- a-Synuclein651 topic
- Deep Brain Stimulation461 topic
- Subthalamic Nucleus461 topic
- Huntington's Disease291 topic
- Protein Aggregation291 topic
- Genetic Mutations262 topics
- Genetic Variants191 topic
- Sequence Interpretation191 topic
- Botulinum Toxin171 topic
- Neurotoxins171 topic
- Brain Iron Accumulation161 topic
- Pantothenate Kinase161 topic
- Epidemiology131 topic
- Restless Legs Syndrome131 topic
- Fragile X Syndrome101 topic
- Rett Syndrome101 topic
Where does Matěj Škorvánek work?
Matěj Škorvánek's main affiliation in the publication record is University of Pavol Jozef Šafárik, Slovakia.
How many publications and citations does Matěj Škorvánek have?
OpenAlex counts 162 works and 3,039 citations for Matěj Škorvánek, an h-index of 31, ranking #533,954 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matěj Škorvánek. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.